España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Vertex Pharmaceuticals
VRTX
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$491.75
0.18
0.04%
Pre-Market: Jul 19, 5:21 PM EDT
15 minutes delayed
Get Report
Comment
Q2 2024 Earnings in 10 days from now on Thu Aug 1st, after the market close
Vertex Pharmaceuticals (VRTX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals Stock (NASDAQ: VRTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 19, 2024
HC Wainwright & Co. Maintains Buy on Vertex P...
Benzinga Newsdesk
Tuesday, July 16, 2024
Genomics Extends And Expansion Drug Discovery...
Benzinga Newsdesk
Monday, July 15, 2024
Vertex Seeks Court Confirmation That Financia...
Benzinga Newsdesk
Vertex Pharmaceuticals Sues U.S. Department O...
Benzinga Newsdesk
Health Canada Grants Marketing Authorization ...
Benzinga Newsdesk
Thursday, July 11, 2024
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Vert...
Benzinga Newsdesk
Wednesday, July 10, 2024
Check Out What Whales Are Doing With VRTX
Benzinga Insights
Tuesday, July 02, 2024
Vertex Pharmaceuticals Announces FDA Acceptan...
Benzinga Newsdesk
Monday, July 01, 2024
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
Benzinga Insights
Thursday, June 27, 2024
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Redburn Atlantic Initiates Coverage On Vertex...
Benzinga Newsdesk
Wednesday, June 26, 2024
Peering Into Vertex Pharmaceuticals's Recent Short Interest
Benzinga Insights
Monday, June 24, 2024
Wells Fargo Maintains Overweight on Vertex Ph...
Benzinga Newsdesk
Friday, June 21, 2024
Vertex Pharmaceuticals Presents New Data From...
Benzinga Newsdesk
Tuesday, June 18, 2024
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
Benzinga Insights
Monday, June 17, 2024
13 Analysts Have This To Say About Vertex Pharmaceuticals
Benzinga Insights
Argus Research Maintains Buy on Vertex Pharma...
Benzinga Newsdesk
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades'
Avi Kapoor
Friday, June 14, 2024
CNBC Halftime Report Final Trades: NVIDIA, Ab...
Benzinga Newsdesk
Vertex Reveals Long-Term Data On CASGEVY (exa...
Benzinga Newsdesk
Tuesday, June 11, 2024
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
RBC Capital Maintains Sector Perform on Verte...
Benzinga Newsdesk
Friday, June 07, 2024
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
Vandana Singh
Vertex To Present New Data Demonstrating Sign...
Benzinga Newsdesk
Wednesday, June 05, 2024
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Tuesday, June 04, 2024
RBC Capital Reiterates Sector Perform on Vert...
Benzinga Newsdesk
Monday, June 03, 2024
This Is What Whales Are Betting On Vertex Pharmaceuticals
Benzinga Insights
Friday, May 31, 2024
Analyst Expectations For Vertex Pharmaceuticals's Future
Benzinga Insights
BMO Capital Maintains Outperform on Vertex Ph...
Benzinga Newsdesk
Tuesday, May 28, 2024
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
Vandana Singh
Thursday, May 23, 2024
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Benzinga Insights
SLB, First Solar And 2 Other Stocks Insiders Are Selling
Avi Kapoor
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
Avi Kapoor
Wednesday, May 22, 2024
CNBC Halftime Report Final Trades: Walmart, V...
Benzinga Newsdesk
Wednesday, May 15, 2024
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
Benzinga Insights
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
Avi Kapoor
Tuesday, May 14, 2024
CNBC Halftime Report Final Trades: Pfizer, Fr...
Benzinga Newsdesk
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Benzinga Insights
Wednesday, May 08, 2024
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
Benzinga Insights
Tuesday, May 07, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?
Piero Cingari
RBC Capital Maintains Sector Perform on Verte...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Vertex ...
Benzinga Newsdesk
Needham Reiterates Hold on Vertex Pharmaceuti...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Vertex ...
Benzinga Newsdesk
Monday, May 06, 2024
Vertex Reiterates FY24 Financial Guidance, In...
Benzinga Newsdesk
Vertex Pharmaceuticals Q1 2024 Adj EPS $4.76 ...
Benzinga Newsdesk
Smart Money Is Betting Big In VRTX Options
Benzinga Insights
Thursday, May 02, 2024
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch